Localized targeted antiangiogenic drug delivery for glioblastoma Gregory D. ArnoneAbhiraj D. BhimaniAnkit I. Mehta Topic Review 11 January 2018 Pages: 223 - 231
Temporal stability of MGMT promoter methylation in glioblastoma patients undergoing STUPP protocol C. J. O’ReganH. KearneyP. G. Buckley Laboratory Investigation 20 December 2017 Pages: 233 - 240
Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma Noble Kumar TalariManas K. PanigrahiPrakash Babu Phanithi Laboratory Investigation 04 January 2018 Pages: 241 - 248
Analysis of immunobiologic markers in primary and recurrent glioblastoma Maryam RahmanJesse KresakDuane Mitchell Laboratory Investigation 04 January 2018 Pages: 249 - 257
A combined diffusion tensor imaging and Ki-67 labeling index study for evaluating the extent of tumor infiltration using the F98 rat glioma model Kai WangTingting HaJianping Dai Laboratory Investigation 02 January 2018 Pages: 259 - 268
Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response Ashley S. PlantShohei KoyamaJerome Ritz Laboratory Investigation 10 January 2018 Pages: 269 - 278
Sex-dependent association of preoperative hematologic markers with glioma grade and progression Wenshen XuDengliang WangLiming Huang Clinical Study 19 December 2017 Pages: 279 - 287
Recursive partitioning analysis is predictive of overall survival for patients undergoing spine stereotactic radiosurgery Ehsan H. BalagamwalaJacob A. MillerSamuel T. Chao Clinical Study 03 January 2018 Pages: 289 - 293
Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis Jaehag JungSeung Hoon LeeHeon Yoo Clinical Study Open access 19 December 2017 Pages: 295 - 302
Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma Deborah R. SmithCheng-Chia WuTony J. C. Wang Clinical Study 20 December 2017 Pages: 303 - 311
Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG) Lei QinAngie LiGeoffrey S. Young Clinical Study 30 January 2018 Pages: 313 - 319
The impact of a mind–body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis Emily L. ZaleCatherine Pierre-LouisAna-Maria Vranceanu Clinical Study 23 December 2017 Pages: 321 - 329
Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma? Pedro GóesBruno Fernandes Oliveira SantosManoel Antônio de Paiva Neto Clinical Study 21 December 2017 Pages: 331 - 336
PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity Kavitha NutakkiJames W. VarniNancy L. Swigonski Clinical Study 22 December 2017 Pages: 337 - 347
Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas Katherine B. PetersEric S. LippHenry S. Friedman Clinical Study 21 December 2017 Pages: 349 - 356
Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies Yu-Long LanXun WangBo Zhang Clinical Study 26 December 2017 Pages: 357 - 365
Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study Jaume CapelladesJosep PuigCarmen Balaña Clinical Study 28 December 2017 Pages: 367 - 377
To drive or not to drive, that is still the question: current challenges in driving recommendations for patients with brain tumours Ann MansurAlexa DesimoneSunit Das Clinical Study 02 January 2018 Pages: 379 - 385
Treatment and outcomes of 28 patients with spinal metastasis from gynecological cancer Xin GaoChenglong ZhaoJianru Xiao Clinical Study 18 January 2018 Pages: 387 - 394
Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma Yuan-Bo PanChi-Hao ZhangDong-Fu Feng Clinical Study 02 January 2018 Pages: 395 - 407
Outcomes after second surgery for recurrent glioblastoma: a retrospective case–control study Alysson WannPatrick A. TullyMustafa Khasraw Clinical Study 02 January 2018 Pages: 409 - 415
Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system Ichiyo ShibaharaMitsuto HaniharaToshihiro Kumabe Clinical Study 21 February 2018 Pages: 417 - 427
Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy David ThibouwGilles TrucCéline Mirjolet Clinical Study 27 January 2018 Pages: 429 - 438
Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients J. N. JakobsenT. UrupH. S. Poulsen Clinical Study 12 January 2018 Pages: 439 - 446
